Sweet Earth Holdings has launched its campaign on the Investing News Network’s cannabis channel.

Sweet Earth Holdings is a vertically-integrated hemp and CBD company cultivating its high-quality products from farms in Applegate Valley, Oregon. The company uses sustainable farming practices without the use of pesticides, herbicides, or chemical fertilizers. By keeping its crop batches small, Sweet Earth Holdings has been able to offer high-quality products that are carefully cultivated using sustainably-sources ingredients.


Sweet Earth Holdings has developed its own collection of proprietary strains at its cultivation facility in Oregon where the natural climate allows for optimal hemp growth. The company uses state-of-the-art greenhouses to ensure its crops return the highest quality. Through the selective breeding of the company’s own genetics, Sweet Earth has developed a 15 percent CBD strain including 1.27 percent CBN and 1.3 percent CBG.

Sweet Earth Holdings’ company highlights include the following:

  • Operates a 100-acre hemp cultivation facility in Appleton, Oregon
  • Facility includes six greenhouses encompassing 30,000 square feet of space designed for selective hemp breeding, planting and R&D
  • US CBD market project to grow at a CAGR of 22.2 percent from 2018 through 2025
  • Sweet Earth has developed over 10 different CBD-based body and skincare products
  • Developing a line of CBD pet products, including several flavors of CBD dog treats
  • Pursuing a diversified approach to distribution including ecommerce sales, retail sales, white label services and wholesale B2B distribution
  • Product ambassador and sponsor Warren Moon is a proponent of CBD and its remedial benefits, specifically the Sweet Earth line
  • CEO Peter Espig, an experienced Wall Street and Goldman Sachs executive, brings global capital market experience to Sweet Earth team

Click here to connect with Sweet Earth Holdings and to request an investor presentation.

  • The Cannabis Derivatives are derived from Avicanna’s cultivation and extraction infrastructure in Santa Marta, Colombia designed to supply partner companies and the manufacture of Avicanna’s own finished products.

Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that, through its majority owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. (“ SMGH ”), it has completed a commercial exports of CBD Isolate and CBD full spectrum psychoactive cannabis resin (the “ Cannabis Derivatives ”) to a leading Chilean homeopathic and naturopathic pharmaceutical company.

The Cannabis Derivatives, branded as Aureus™, are cultivated, extracted, and manufactured by SMGH. In addition, for Avicanna’s global input needs, SMGH also supplies other pharmaceutical and cosmetics companies with cannabinoids including CBD, THC, and rare cannabinoids such as CBG in addition to supplying global cultivation companies with standardized and feminized seeds. This new export to Chile is a recurring order and part of on-going relationship with an established homeopathic Chilean company.

Keep reading... Show less

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2022 ended September 30, 2021 before financial markets open on November 5, 2021 .

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary in Wyomissing, Pennsylvania. Wyomissing will be Cresco Labs’ fifth dispensary in Pennsylvania and 38 th nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211021006075/en/

Keep reading... Show less

The world of cannabis consumption is set to change radically, thanks in large part to the advancement of state-of-the-art research on the plant itself.

Medical cannabis products have already allowed many new users to discover the plant’s potential, but decisive research will help build a foundation for more sophisticated medical offerings.

Keep reading... Show less

ADASTRA HOLDINGS LTD. ENGAGES HYBRID FINANCIAL LTD.

Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) (“Adastra”, or the “Company”) is pleased to announce that it has retained Hybrid Financial Ltd. (“Hybrid”) to provide marketing services to the Company. Hybrid has been engaged to heighten market and brand awareness for Adastra and to broaden the Company’s reach within the investment community.

Keep reading... Show less